Yvonne Greenstreet insider trades
Open-market stock purchases and sales by Yvonne Greenstreet, Chief Executive Officer at Alnylam Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 4, 2014.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 19, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $86.3K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $43.1K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $41.3K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $87.9K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $118K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $143K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $315K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $112K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $124K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $358K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $64.7K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $545K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $458K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $139K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $238K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $114K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $132K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $53.2K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 27, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 13, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $2.2M |
| Feb 12, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |